Peanut gastrointestinal delivery oral immunotherapy in adolescents: Results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study).
Jean-Luc FauquertE MichaudB PereiraL BernardN Gourdon-DuboisP-O RouzaireE RochetteE MerlinBertrand Evrardnull nullPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2018)
The GIDOIT protocol demonstrated clinical and immunological efficacy and had an acceptable level of safety with weak oropharyngeal symptoms, no dysphagia, mild digestive events and few severe systemic AE.